EN DE
Watch ORGANIC Farma Zdrowia S.A for free: we tell you when fair value or trend changes.
Data-driven stock valuation

ORGANIC Farma Zdrowia S.A (ORG) fair value: what the stock is really worth

As of Nov 4, 2026: fair value (intrinsic value) of ORGANIC Farma Zdrowia S.A stock PLN 4.44, price PLN 10.30, that is 56.9% below the price, quality 54 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive PL · ISIN PLORGNK00010

OF Some data Nov 4, 2026

ORGANIC Farma Zdrowia S.A

ORG · WAR
Stretched Valuation

Our calculation puts a fair price 57% below what the stock costs today.

Quality 54/100
Expensive Growth (revenue 3y +9.3 %/yr in PLN)
Thin margins · 0.8% net margin (TTM)
Moderate debt
Some data
Fair value 4.44 PLN · Strongly overvalued (−56.9%)
Negative free cash flow
Trails peers (3/12)
Narrow moat 32/100
⚠ Small free float
Watch ORGANIC Farma Zdrowia S.A for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

11.10 PLN 8.60 PLN Fair Value 4.44 PLN Jul 2026 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.

How to read this chart

4‑month range 8.60 PLN – 11.10 PLN · fair‑value band 3.37 PLN – 5.77 PLN · the 10.30 PLN price screens above the 4.44 PLN fair value. As of Nov 4, 2026.

Follow ORGANIC Farma Zdrowia in your weekly email

Every Wednesday you see whether ORGANIC Farma Zdrowia is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

ORGANIC Farma Zdrowia S.A. retail sale of ecological products in Poland and internationally. The company offers ecological and traditional food, cosmetics, and personal and home hygiene products.

Show moreShow less

It also provides groceries/healthy food products, milk, dairy products, eggs, bakery and pastry products, fresh fruits, vegetables, herbs, ready meals, plant-based cuisine products, meat, cold cuts, fish and seafood, drinks, diets, dietary products, supplements and vitamins, natural drug products, ecological cleaning products, zero waste, frozen foods, and wine, beer, meads, and caffeinated drinks, as well as products for children.

The company also sells its products through its online stores. ORGANIC Farma Zdrowia S.A. was incorporated in 2007 and is headquartered in Warsaw, Poland.

Stock analysis

ORGANIC Farma Zdrowia S.A (ORG) currently trades at 10.30 PLN, while our model-based Fair Value estimate is 4.44 PLN, 57% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 5.49 PLN per share, and 0 of the 14 models we run sit above the 10.30 PLN price.

Bear case: the Asset-Based group reads lowest at 0.7400 PLN, and 14 of the 14 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 3.37 PLN (bear) to 5.77 PLN (bull), the price of 10.30 PLN sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 54/100 (solid quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

ORGANIC Farma Zdrowia S.A reported revenue of 134M PLN in FY2025 versus 103M PLN in FY2022, a compound +9.3%/yr. Reported net income was 1.4M PLN in FY2025.

Key figures

Market cap 56.7M PLN (≈ $14.5M) Micro · P/E ratio 51.5 · P/S ratio 0.40 · EPS (TTM) 0.2000 PLN · Net margin 0.8% · Return on equity 17.5% · Return on assets (EBIT) 1.8% · Operating margin 0.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).

What moves the price

For context, the median of 10 Consumer Defensive peers we cover trades at −21% fair-value upside, at −57%, ORG screens richer than that median.

Fair Value models

Bear 3.37 PLN Fair Value 4.44 PLN Bull 5.77 PLN
Price 10.30 PLN · Downside -56.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.1693 PLN per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV 3.06 PLN 3.53 PLN 3.93 PLN 71
ROIC Compounder 3.37 PLN 4.29 PLN 5.35 PLN 69
EV/EBITDA 7.19 PLN 9.97 PLN 12.75 PLN 67
All 14 models by family
Earnings-Based
Graham-Dodd 1.74 PLN 7.16 PLN 9.76 PLN 61
Lynch FV 1.80 PLN 2.58 PLN 3.35 PLN 58
PEG = 1.0 1.80 PLN 2.58 PLN 3.35 PLN 55
EPV 3.06 PLN 3.53 PLN 3.93 PLN 71
Multiples
P/E Multiple 4.03 PLN 5.37 PLN 6.71 PLN 63
P/S Multiple 3.26 PLN 4.35 PLN 5.43 PLN 58
P/B Multiple 4.56 PLN 6.07 PLN 7.59 PLN 55
EV/EBIT 5.36 PLN 7.54 PLN 9.71 PLN 65
EV/EBITDA 7.19 PLN 9.97 PLN 12.75 PLN 67
EV/Revenue 3.50 PLN 5.49 PLN 7.49 PLN 53
Asset-Based
NCAV (Graham) 0.5500 PLN 0.7400 PLN 1.10 PLN 54
Economic Profit
Residual Income 1.41 PLN 1.87 PLN 3.20 PLN 65
ROIC Compounder 3.37 PLN 4.29 PLN 5.35 PLN 69
Growth Earnings
Growth-Adj P/E 3.11 PLN 4.44 PLN 5.77 PLN 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 54/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 67
How much profit the company makes from its sales and capital
Quality Growth 36
Are margins and returns getting better?
Cashflow 17
Do the profits arrive as real cash?
Financial strength 42
Debt, balance sheet and risk of trouble
Investment 96
Does it invest with discipline instead of growing at any price?
Low Volatility 100
How calm the share price moves, does not count
Near the 52-week high 55
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 52/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+11.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.3%
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−42.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−42.6%
Dividend (yield on the price)0.0%
Profit margin 2022 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−4% → 2%

ORG screens overvalued: fair value 57% below the price. Compare with Loblaw Companies Limited →

Compare ORGANIC Farma Zdrowia S.A with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Grocery Stores · 74 stocks

Beats the industry median on 3/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 54 · Below median
Fair Value upside −56.9% · Bottom 25%
Profitability
Return on equity (12 months) 17.5% · Above median
Return on assets 4.0% · Below median
Net margin (12 months) 0.8% · Bottom 25%
Operating margin (12 months) 0.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 4.9% · Above median
Balance sheet
Debt / equity 0.67× · Highest 25%

Valuation Multiplesvs Grocery Stores median · lower = cheaper

P/E (12 months) 51.5× · Priciest 25%
P/B 9.33× · Priciest 25%
P/S (12 months) 0.40× · Cheaper than median
EV/EBITDA 11.7× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 40
FUTURE (revenue growth)25 · sector 14
PAST (return on equity)70 · sector 51
HEALTH (low debt)67 · sector 90
DIVIDEND (yield)0 · sector 53

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Grocery Stores stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Koninklijke Ahold Delhaize N.V AD €34.29 €54.03 +58% vs ORG
CP ALL Public Company CPALL 44.00 THB 58.24 THB +32% vs ORG
Metro Inc MRU C$99.96 C$97.54 −2% vs ORG
Carrefour SA CA €13.46 €12.62 −6% vs ORG
The Kroger Co KR $68.97 $54.76 −21% vs ORG
George Weston Limited WN C$111.50 C$72.52 −35% vs ORG
Loblaw Companies Limited L C$70.43 C$44.76 −36% vs ORG
Dino Polska S.A DNP 38.34 PLN 19.69 PLN −49% vs ORG
Kesko Oyj KESKOB €26.60 €13.16 −51% vs ORG
Woolworths Group WOW A$41.72 A$19.56 −53% vs ORG

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

ORGANIC Farma Zdrowia S.A: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "ORGANIC Farma Zdrowia S.A Fair Value". https://www.fairvalue-calculator.com/stock/ORG.WAR

Frequently asked questions

Is ORGANIC Farma Zdrowia S.A (ORG) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 4.44 PLN versus a price of 10.30 PLN, about 57% lower (overvalued).
What is the fair value of ORG?
Our model-based fair value for ORGANIC Farma Zdrowia S.A is 4.44 PLN (as of Nov 4, 2026), built from audited fundamentals. The current price: 10.30 PLN.
What is the quality score of ORG?
ORGANIC Farma Zdrowia S.A has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ORGANIC Farma Zdrowia S.A (ORG)?
Our model-based price target is the fair value of 4.44 PLN (as of Nov 4, 2026) from 14 valuation models. Cautious scenario 3.37 PLN, optimistic scenario 5.77 PLN. It is a calculation from audited fundamentals, not an analyst target.
What is the ORGANIC Farma Zdrowia S.A stock forecast for 2026?
Our models put fair value at 4.44 PLN, about 57% lower versus a price of 10.30 PLN (overvalued). Cautious scenario 3.37 PLN, optimistic scenario 5.77 PLN. The calculation is refreshed regularly with new filings.
What is the revenue of ORGANIC Farma Zdrowia S.A (ORG)?
ORGANIC Farma Zdrowia S.A reported trailing-twelve-month revenue of about 141M PLN (latest available figure, as of Nov 4, 2026).
What is the intrinsic value of ORGANIC Farma Zdrowia S.A (ORG)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ORGANIC Farma Zdrowia S.A it is 4.44 PLN per share (as of Nov 4, 2026), against a price of 10.30 PLN. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is ORGANIC Farma Zdrowia S.A stock overvalued or undervalued in 2026?
As of Nov 4, 2026, ORG trades above its calculated fair value: price 10.30 PLN, fair value 4.44 PLN, a gap of about −57% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ORG?
No. The price is what the market pays today (10.30 PLN); the fair value is what the company's own numbers justify (4.44 PLN). For ORGANIC Farma Zdrowia S.A the two are 5.86 PLN per share apart. That gap is exactly why we show both numbers side by side.
How much is ORGANIC Farma Zdrowia S.A worth?
The market values ORGANIC Farma Zdrowia S.A at about 56.7M PLN (market capitalisation, as of Nov 4, 2026). Per share that is 10.30 PLN; our models calculate a fair value of 4.44 PLN per share.
What do the bullish and bearish scenarios say about ORG?
Our models span a range for ORGANIC Farma Zdrowia S.A: cautious scenario 3.37 PLN, base 4.44 PLN, optimistic 5.77 PLN per share (as of Nov 4, 2026, price 10.30 PLN). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of ORG?
ORGANIC Farma Zdrowia S.A trades at a price-to-earnings ratio of 51.5 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 4.44 PLN is built from several models across several years. Other multiples: P/B 9.3, P/S 0.4, EV/EBITDA 11.7.
How solid is the balance sheet of ORGANIC Farma Zdrowia S.A (ORG)?
Balance-sheet figures for ORGANIC Farma Zdrowia S.A (as of Nov 4, 2026): return on equity 17.5%, debt of 0.67 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
Which stocks are comparable to ORGANIC Farma Zdrowia S.A?
From the same area (Consumer Defensive) we also value Loblaw Companies Limited, The Kroger Co, Woolworths Group, Koninklijke Ahold Delhaize N.V, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ORGANIC Farma Zdrowia S.A stock attractive at the current price?
The data as of Nov 4, 2026: price 10.30 PLN, calculated fair value 4.44 PLN (−57%), Quality Score 54/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ORG calculated?
We run ORGANIC Farma Zdrowia S.A through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 4.44 PLN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0% above its aggregate fair value. ORGANIC Farma Zdrowia S.A itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ORGANIC Farma Zdrowia S.A (ORG)?
The closing price on Nov 4, 2026 was 10.30 PLN. Our model-based fair value is 4.44 PLN, about 57% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ORGANIC Farma Zdrowia S.A right now?
The price sits above even our optimistic bull case (5.77 PLN). The favourable scenario is already priced in. Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of ORGANIC Farma Zdrowia S.A

How large is the market capitalisation of ORGANIC Farma Zdrowia S.A (ORG)?
The market capitalisation of ORGANIC Farma Zdrowia S.A is 56.7M PLN (≈ $14.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of ORGANIC Farma Zdrowia S.A (ORG)?
The price-to-sales ratio of ORGANIC Farma Zdrowia S.A is 0.40 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of ORGANIC Farma Zdrowia S.A (ORG)?
Earnings per share at ORGANIC Farma Zdrowia S.A are 0.2000 PLN (price ÷ EPS = P/E 51.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of ORGANIC Farma Zdrowia S.A (ORG)?
The net margin of ORGANIC Farma Zdrowia S.A is 0.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of ORGANIC Farma Zdrowia S.A (ORG)?
The return on equity (ROE) of ORGANIC Farma Zdrowia S.A is 17.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of ORGANIC Farma Zdrowia S.A (ORG)?
On an EBIT basis the return on assets of ORGANIC Farma Zdrowia S.A is 1.8% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of ORGANIC Farma Zdrowia S.A (ORG)?
The operating margin of ORGANIC Farma Zdrowia S.A is 0.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at ORGANIC Farma Zdrowia S.A (ORG)?
Revenue at ORGANIC Farma Zdrowia S.A is growing +4.9% versus a year earlier (3y avg +9.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does ORGANIC Farma Zdrowia S.A (ORG) generate?
The free cash flow of ORGANIC Farma Zdrowia S.A is −793K PLN (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does ORGANIC Farma Zdrowia S.A (ORG) carry?
The net debt of ORGANIC Farma Zdrowia S.A is 6.4M PLN (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch ORGANIC Farma Zdrowia S.A in the live analysis

One click puts ORGANIC Farma Zdrowia S.A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.